CBSC OTC
Cardiac Biotech Solutions Inc.
1W: +12.9%
1M: -12.3%
3M: -12.1%
YTD: -12.5%
1Y: -30.0%
3Y: -79.7%
5Y: -91.3%
$0.04
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$41K
-69.3% ▼
5Y CAGR: -19.4%
Gross Profit
$41K
-69.3% ▼
Operating Income
-$1M
+16.8% ▲
Net Income
-$2M
-3.1% ▼
EPS (Diluted)
$-0.01
+9.4% ▲
EBITDA
-$2M
-4.3% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Revenue | $32K | $76K | $82K | $135K | $41K |
| YoY Growth | -73.4% | +133.0% | +9.0% | +63.9% | -69.3% |
| Cost of Revenue | $10K | $149K | $42K | $0 | $0 |
| Gross Profit | $23K | -$74K | $40K | $135K | $41K |
| Gross Margin | 69.8% | -97.5% | 48.7% | 100.0% | 100.0% |
| R&D Expenses | $0 | $0 | $485K | $420K | $173K |
| SG&A Expenses | $3M | $2M | $2M | $1M | $1M |
| Operating Expenses | $3M | $2M | $2M | $2M | $1M |
| Operating Income | -$3M | -$2M | -$2M | -$2M | -$1M |
| Operating Margin | -9071.5% | -2475.4% | -2550.7% | -1181.5% | -3207.4% |
| Interest Expense | $344K | $2M | $5K | $5K | $222K |
| Income Before Tax | -$4M | -$6M | -$2M | -$2M | -$2M |
| Tax Expense | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$4M | -$6M | -$2M | -$2M | -$2M |
| Net Margin | -13341.4% | -8391.9% | -2556.4% | -1207.1% | -4059.9% |
| EPS (Diluted) | $-0.06 | $-0.07 | $-0.02 | $-0.01 | $-0.01 |
| EBITDA | -$4M | -$5M | -$2M | -$2M | -$2M |
| Shares Outstanding | 78M | 91M | 119M | 140M | 159M |